Patent · US Active

Drug-eluting medical device

US10874770B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2020
Grant dateDec 29, 2020
Priority date
Expiry dateMar 19, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2025/105
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.